Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
04 2020
Historique:
received: 20 07 2019
revised: 15 01 2020
accepted: 17 01 2020
pubmed: 28 1 2020
medline: 26 8 2021
entrez: 28 1 2020
Statut: ppublish

Résumé

Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine and sacroiliac joints with unidentified etiology closely associated with metabolic syndrome (MetS). Recent studies have reported that immunological and oxidative stress factors are implicated in AS pathogenesis. The aim of this study was to investigate the oxidative and immunological factors in AS patients with or without MetS compare to control group. Real-Time PCR measured expression level of cytokines, transcription factors and related miRNAs. In addition, Th17 and Treg frequencies and cytokines secretion were evaluated by flowcytometry and ELISA methods, respectively. The oxidative stress biomarkers were also assessed with biochemical methods. In AS patients with MetS, higher Th17 and lower Treg frequency were observed. Increased levels of NF-kB and AP-1 mRNA expression were seen in AS patients with MetS (p = 0.0263 and p = 0.0104, respectively). MiR-146a and miR-223 were significantly decreased (p = 0.0005, p = 0.0161, respectively) and increase in miR-21 (p = 0.0002) was observed in AS patients with MetS compared to AS patients without MetS. Additionally, the secretion of TNF-α (p = 0.0167), IL-1β (p = 0.303), CCL2 (p = 0.0254), CCL3 (p = 0.0119), CXCL8 (p = 0.0364), adiponectin (p = 0.0183) and the levels of SOD (p = 0.0421), NO (p = 0.0451) and CAT (p = 0.0128) were increased in AS patients with MetS. We were not observed significant differences in TOS and GPX levels between studied groups. The higher levels of oxidative stress and immunological inflammatory markers in AS patients with MetS provide further evidences on the oxidative stress and immunological relationship in these patients.

Identifiants

pubmed: 31986444
pii: S1043-4666(20)30018-1
doi: 10.1016/j.cyto.2020.155002
pii:
doi:

Substances chimiques

Adiponectin 0
Biomarkers 0
Cytokines 0
Interleukin-1beta 0
MicroRNAs 0
NF-kappa B 0
Transcription Factors 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

155002

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alireza Pishgahi (A)

Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Rozita Abolhasan (R)

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Shahla Danaii (S)

Gynecology Department, Eastern Azerbaijan ACECR ART Center, Eastern Azerbaijan Branch of ACECR, Tabriz, Iran.

Bahareh Amanifar (B)

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad Sadegh Soltani-Zangbar (MS)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Majid Zamani (M)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Amin Kamrani (A)

Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Farzaneh Ghorbani (F)

Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Amir Mehdizadeh (A)

Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Comprehensive Health Lab, Tabriz University of Medical Sciences, Tabriz, Iran.

Hossein Samadi Kafil (HS)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Farhad Jadidi-Niaragh (F)

Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Bahman Yousefi (B)

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehrzad Hajialiloo (M)

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mehdi Yousefi (M)

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: yousefime@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH